BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Army
Argus Health
Harvard Business School
Boehringer Ingelheim

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for Patent: RE44048

« Back to Dashboard

Summary for Patent: RE44048

Title:4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonami- de for the treatment of inflammation or an inflammation-associated disorder
Abstract: .[.A class of pyrazolyl benzenesulfonamide compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula II: ##STR00001## or a pharmaceutically-acceptable salt thereof..]. .Iadd.A method of treating inflammation or an inflammation-associated disorder in a subject by administering a therapeutically-effective dose of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonam- ide, or a pharmaceutically-acceptable salt thereof, to the subject..Iaddend.
Inventor(s): Talley; John J. (St. Louis, MO), Bertenshaw; Stephen R. (Cheshire, CT), Miyashiro; Julie M. (Morton Grove, IL)
Assignee: G.D. Searle LLC (New York, NY)
Application Number:12/205,319
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: RE44048

PCT Information
PCT FiledNovember 14, 1994PCT Application Number:PCT/US94/12720
PCT Publication Date:June 08, 1995PCT Publication Number: WO95/15316

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus